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Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH), also known as Fowler syndrome, is an autosomal-
recessively inherited prenatal lethal disorder characterized by hydranencephaly; brain stem, basal ganglia, and spinal cord diffuse clastic
ischemic lesions with calciﬁcations; glomeruloid vasculopathy of the central nervous system and retinal vessels; and a fetal akinesia
deformation sequence (FADS) with muscular neurogenic atrophy. To identify the molecular basis for Fowler syndrome, we performed
autozygosity mapping studies in three consanguineous families. The results of SNP microarrays and microsatellite marker genotyping
demonstrated linkage to chromosome 14q24.3. Direct sequencing of candidate genes within the target interval revealed ﬁve different
germline mutations in FLVCR2 in ﬁve families with Fowler syndrome. FLVCR2 encodes a transmembrane transporter of the major facil-
itator superfamily (MFS) hypothesized to be involved in regulation of growth, calcium exchange, and homeostasis. This is the ﬁrst gene
to be associated with Fowler syndrome, and this ﬁnding provides a basis for further studies to elucidate the pathogenetic mechanisms
and phenotypic spectrum of associated disorders.In 1972, Fowler et al.1 described a family in which ﬁve
sisters were affected by a prenatally lethal disorder diag-
nosed between 26 and 33 wks of gestation. Examination
showed ‘‘bubble-like’’ cerebral hemispheres with no
discernible gyral pattern, as well as a distinctive glomeru-
loid vascular proliferation in the central nervous system
and retina. Polyhydramnios, fetal akinesia deformation
sequence (FADS [MIM 208150]), and muscular neurogenic
atrophy were also apparent. The disorder has subsequently
been reported as Fowler syndrome, proliferative vasculop-
athy and hydranencephaly-hydrocephaly (PVHH), or
encephaloclastic proliferative vasculopathy (EPV [MIM
225790]) and is inherited as an autosomal-recessive trait.
Fowler syndrome is rare (fewer than 40 cases have been
described1–13), but it is likely to be underdiagnosed because
neuropathology is not available for many cases of FADS.
Hence, the availability of accurate genetic testing for
Fowler syndrome would facilitate diagnosis and improve
family management. In order to map and identify a gene
for Fowler syndrome, we initially investigated three
consanguineous families of Pakistani origin (families 1–3)
by using an autozygosity mapping strategy. A total of ﬁve
kindreds (containing seven fetuses with Fowler syndrome)
were analyzed by direct sequencing of candidate genes
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summarized in Table 1.
All parents gave written informed consent. The study
was approved by South Birmingham Local Research Ethics
Committee and was performed in accordance with the
Declaration of Helsinki. Genomic DNA from the affected
fetuses was extracted from fetal tissues, placenta material,
and amniotic ﬂuid, respectively. Furthermore, genomic
DNA from parents and some unaffected siblings of two
of the ﬁve families (families 1 and 2) was extracted from
peripheral lymphocytes and buccal swabs by standard
techniques, respectively.
We ﬁrst performed a genome-wide linkage scan by using
Affymetrix 250k SNP microarrays (Affymetrix), in cases 1
and 2 of family 1 and case 3 of family 2, to identify regions
of homozygosity (> 2 Mb) that were common to all cases.
DNA was ampliﬁed and hybridized to the Affymetrix SNP
chip according to the manufacturer’s instructions. Two
extended overlapping regions of homozygosity on chro-
mosome 14 (12.56 Mb [from rs10134110 to rs1205233;
57,642,936–70,202,512] and 24.65 Mb [from rs7160623
to rs1952299; 72,140,408–96,793,024 according to NCBI
build 36.3]) shared by the three fetuses from families 1
and 2 were identiﬁed. Further genotyping with microsatel-
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Table 1. Summary of Major Clinical Findings in the Seven Fetuses with Fowler Syndrome
Case
Gestation
at Diagnosis Ultrasound Findings Pathological Findings Karyotype
Family 2
3 19 wks Ventriculomegaly, joint contractures
upper and lower limbs, talipes
Hydrocephalus, cortical thinning, pterygia,
polymicrogyria, muscle hypoplasia, cleft
palate. Glomeruloid vascular proliferation
(cerebral cortex, cerebellum, brain stem).
46XX
4 21 wks Intrauterine death Cortical thinning, hydranencephaly.
Glomeruloid vascular proliferation (cerebral
cortex, cerebellum, brain stem). Joint




1 21 wks Ventriculomegaly, joint contractures
upper and lower limbs, talipes,
non-visualized cerebellum
Hydrocephalus, cortical thinning. Glomeruloid
vascular proliferation (cerebral cortex,
cerebellum, brain stem, spinal cord).
46XY
2 16 wks Cystic hygroma, ventriculomegaly,
joint contractures upper and lower
limbs, talipes, hydranencephaly
Hydrocephalus, cortical thinning, hydranencephaly.
Glomeruloid vascular proliferation (cerebral cortex,
cerebellum, brain stem, spinal cord).
46XY
Family 3
5 20 wks Ventriculomegaly and a posterior
fossa cyst, cerebellum not seen
Dandy-Walker malformation (1.5cm posterior
fossa cyst, small cerebellum); marked bilateral
ventriculomegaly, cortical thinning, glomeruloid




6 13 wks Ventriculomegaly, joint contractures
upper and lower limbs, pterygia, talipes
Hydrocephalus, cortical thinning. Severely
hypoplastic brain stem, cerebellum and
spinal cord. Glomeruloid vascular
proliferation (cerebral cortex, cerebellum,
brain stem, spinal cord).
46XY
Family 5
7 24 wks Ventriculomegaly, joint contractures
upper and lower limbs, talipes,
hydranencephaly
Hydrocephalus, cortical thinning, hydranencephaly.
Severely hypoplastic brain stem, cerebellum and
spinal cord. Glomeruloid vascular proliferation
(cerebral cortex, cerebellum, brain stem, spinal cord).
46XXof families 1 and 2, as well as in the more recently ascer-
tained case 4 of family 2 and case 5 of family 3 (informa-
tion on primer sequences and the physical order of the
markers was obtained from the NCBI database and the
UCSC browser, respectively). Linkage to the 12.56 Mb
region on chromosome 14 was excluded by the ﬁnding
of heterozygous alleles in case 4 of family 2 (data not
shown). However, genotyping of microsatellite markers
within the second region conﬁrmed that affected fetuses
were homozygous and that one unaffected sibling was
heterozygous (Figure 1). Upon comparison of the microsa-
tellite marker data of cases 1–5, a common haplotype was
identiﬁed in the three consanguineous families of Pakis-
tani ancestry (from 74.87 Mb to 78.97 Mb). This common
haplotype was conﬁrmed, and the candidate region was
narrowed by the SNP microarray results showing for cases
1–3 an identical homozygous genotype between SNPs
rs4148077 and rs11622335 (from 73.83 Mb to 75.87
Mb). Multipoint linkage analysis for families 1 and 2
gave a combined maximum LOD score of 3.69 at D14S61
(family 1, 1.81; family 2, 1.88).472 The American Journal of Human Genetics 86, 471–478, March 1Wehypothesized that the three consanguineous families
of Pakistani origin (families 1–3) might share a common
mutation, and we focused on the region of the shared
haplotype at 14q24.3 (from 74.87 Mb to 75.87 Mb) that
contained ten known genes, pseudogenes, and hypothet-
ical proteins. Mutation analysis of genes in this region
was undertaken by direct sequencing with the use of the
Big Dye Terminator Cycle Sequencing System and with
use of an ABI PRISM 3730 DNA Analyzer (Applied Biosys-
tems). The genomic DNA sequence of the genes was taken
from Ensembl, and primer pairs for the translated exons
were designed with primer3 software. Sequencing of Jun
dimerization protein 2 (JDP2 [MIM 608657]), basic leucine
zipper transcription factor, ATF-like (BATF [MIM 612476]),
chromosome 14 open reading frame 1 (C14orf1 [MIM
604576]), transforming growth factor, beta 3 (TGFB3
[MIM 190230]), chromosome 14 open reading frame 179
(C14orf179), and chromosome 14 open reading frame
118 (C14orf188) did not reveal any pathogenic variants.
However, a homozygous missense mutation, c.1289C>G
(p.Thr430Arg), was detected in exon 7 of feline leukemia2, 2010
Figure 1. Pedigrees and Linkage Analysis Results for Three Consanguineous Families with Fowler Syndrome
The results of the microsatellite marker analysis for chromosome 14 of the three Pakistani families 1, 2 and 3 are shown (localization of
markers according to NCBI build 36.3). The markers of the assumed common homozygous haplotype are highlighted (red box).virus subgroup C cellular receptor family, member 2
(FLVCR2 or C14orf58 or FLJ20371 [MIM 610865]) in all
ﬁve affected fetuses in families 1–3 (Figure 2A). This muta-
tion cosegregated with the disease in families 1 and 2 and
was not detected in 646 control chromosomes (354 alleles
from Asian individuals and 292 alleles from individuals of
European descent). Sequence alignment showed Thr430
to be conserved down to C. elegans (Figure 3A), and the
missense mutation at this position was predicted to be
damaging by bioinformatic analysis with PolyPhen (PSIC
score 2.256) and SIFT. After the identiﬁcation of the puta-
tive missense mutation in FLVCR2, mutation analysis was
performed in two additional recently ascertained Fowler
syndrome cases (cases 6 and 7) from two nonconsanguine-
ous kindreds ofNorthern European origin. Case 6 (family 4)
was compound heterozygous for a 6 bp deletion,
c.329_334del (p.Asn110_Phe112delinsIle), in exon 1 and
a missense mutation, c.1192C>G (p.Leu398Val), in exon 6
(Figure 2B). Case 7 (family 5) was compound heterozygous
for a nonsense mutation, c.473C>A (p.Ser158X), in exon 1
and a missense mutation, c.839C>G (p.Pro280Arg), inThe Ameriexon 3 (Figure 2C). Both the Leu398 and the Pro280 resi-
dues are highly conserved (Leu398 is conserved in Danio
rerio and C. elegans but not in Drosophila melanogaster
[Figure 3A], and Pro280 is conserved in all FLVCR2 ortho-
logs [Figure 3B]). The 6 bp deletion removed three
conserved amino acids (three conserved to Danio rerio and
two to C. elegans [Figure 3C]) and produced a missense
substitution.None of the identiﬁedmutationswas detected
in at least 936 control chromosomes (346 alleles fromAsian
individuals and 590 alleles from individuals of European
descent).
In total, ﬁve different mutations, including three mis-
sense variants, one nonsense mutation, and one deletion/
insertion change, have been found in FLVCR2 (Table 2).
FLVCR2 is a protein with 12 predicted transmembrane
domains that belongs to the major facilitator superfamily
(MFS) of secondary carriers that transport small solutes in
response to chemiosmotic ion gradients.14 The complex
amino acid deletion/insertion mutation occurs in the pre-
dicted ﬁrst extracellular loop, whereas the missense substi-
tutions at amino acid residues 280 and 430 arise withincan Journal of Human Genetics 86, 471–478, March 12, 2010 473
Figure 2. Sequences of the FLVCR2 Mutations
(A) Chromatograms of mutation c.1289C>G in Pakistani families 1, 2 and 3. Top row: The sequence chromatogram of a control sample
with wild-type allele. Middle row: The sequence chromatogram of an affected fetus with the homozygous variant (c.1289G/G). Bottom
row: The sequence chromatogram of a parent with the heterozygous mutation (c.1289C/G).
(B) Chromatograms ofmutations c.329_334 del (panel left) and c.1192C>G (panel right) in families 4. Top row: The sequence chromato-
gram of a control sample with wild-type alleles. Bottom row: The sequence chromatogram of an affected fetus with the heterozygous
deletion and heterozygous C to G substitution (c.1192C/G).
(C) Chromatograms of variants c.473C>A (panel left) and c.839C>G (panel right) in families 5. Top row: The sequence chromatogram of
a control sample with wild-type alleles. Bottom row: The sequence chromatogram of an affected fetus with the heterozygous changes
(c.473C/A and c.839C/G).intracellular loops, and the amino acid residue 398 is
located in or in close proximity to transmembrane
domain 9. The nonsense mutation occurs in the predicted
transmembrane domain 3 and results (in the absence of
nonsense-mediated decay) in a 158 aa protein that lacks
the remaining nine transmembrane domains (Figure 4).
The precise consequence of these mutations is difﬁcult to
establish, but it is conceivable that they may cause local
conformational changes altering the function of the
protein, such as selectivity or transport performance.
The exact function of the putative transporter FLVCR2
and its speciﬁc substrate is still unclear. FLVCR2 and its
paralog feline leukemia virus subgroup C cellular receptor474 The American Journal of Human Genetics 86, 471–478, March 11 (FLVCR1 [MIM 609144]) share 60% amino acid sequence
identity across their 12 transmembrane domains and were
apparently involved in chromosomes 1q/14q block dupli-
cation.15 FLVCR1 is a human exporter of heme that is
essential for erythropoiesis and serves as a receptor for
feline leukemia virus subgroup C.16 Feline leukemia viruses
(FeLVs) are pathogenic retroviruses of domestic cats that
induce proliferative, degenerative, and immunosuppres-
sive disorders. FeLV-A is the primary strain, and FeLV-C
was formed by mutations in the FeLV-A Env gene. FeLV-C
is tightly associated with red blood cell aplasia caused by
speciﬁc disruption in erythroid progenitor cell develop-
ment. Whereas FeLV-A viruses infect cells through theFigure 3. Conservation of Mutated
FLVCR2 Amino Acid Residues
Seven representative sequences of Bilateria
for FLVCR2 are aligned (*predicted amino
acid sequences). The affected amino acid
residues are shown in red and bold. Resi-
dues matching the human FLVCR2
sequence are in gray and those not match-
ing the sequence are in white. Residues
which are conserved in all seven sequences
are in dark gray.
(A) Leu398 in exon 6 and Thr430 in
exon 7.
(B) Pro280 in exon 3.
(C) Asn110_Phe112 in exon 1.
2, 2010
Table 2. FLVCR2 Mutations Identified in the Five Families with Fowler Syndrome
Patient Nucleotide Level Protein Level Type of Mutation Exon
Cases 1 and 2 (family 1) c.1289C>G p.Thr430Arg missense 7
Cases 3 and 4 (family 2) c.1289C>G p.Thr430Arg missense 7
Case 5 (family 3) c.1289C>G p.Thr430Arg missense 7
Case 6 (family 4) c.329_334del p.Asn110_Phe112delinsIle deletion/insertion 1
c.1192C>G p.Leu398Val missense 6
Case 7 (family 5) c.473C>A p.Ser158X nonsense 1
c.839C>G p.Pro280Arg missense 3solute carrier family 19 (thiamine transporter), member 2
(SLC19A2 or THTR1 [MIM 603941]), FeLV-C strains utilize
the heme exporter FLVCR1.15–17 Disruption of FLVCR1
speciﬁcally disrupts early erythropoiesis and mimics
FeLV-C-induced anemia in cats. Recently, a FeLV-C strain
was identiﬁed that caused pure red cell aplasia and, as
a result of a Env mutation, can use FLVCR1, THTR1, and
FLVCR2 for infection.18 An interesting inference of this
ﬁnding is that, because retroviruses often use structurally
and functionally related proteins as receptors, FLVCR1
and FLVCR2 may have related functions. FLVCR1 null
mice die in utero at one of two embryonic times (at or
before embryonic day [E]7.5 and between E14.5 and
E16.5) and demonstrate developmental defects most
prominently at E14.5, including abnormal limb, hand,
and digit maturation, ﬂattened faces, and hypertelorism
(in addition to defective erythropoiesis).19
It has been previously suggested that the FLVCR2 trans-
porter is speciﬁc for a calcium-chelate complex and is
involved in the regulation of growth and calcium metabo-
lism.20 We note that the proliferation and motility of
vascular endothelial cells (ECs), which are major processes
in angiogenesis and the induction of CNS vascularization,
are calcium-dependent events. These processes require
interaction of endothelial cells with the extracellularThe Amerimatrix and associated support cells (pericytes),21 and it is
interesting that a recent study suggested that the patho-
genesis of the cerebral proliferative glomeruloid vasculop-
athy might be related to a possible deﬁcit of pericytes.12
The glomeruloid vasculopathy seen in Fowler syndrome
is pathognomonic, can occur throughout the brain and
spinal cord, and is associated with varying degrees of calci-
ﬁcation and necrosis in the white matter, basal ganglia,
brainstem, cerebellum, and spinal cord.4 The proliferative
glomeruloid vasculopathy can also occur in the optic nerve
but does not appear outside of the CNS. Nevertheless,
although there is a close association between the vascular
and CNS lesions, it is unclear which process is the primary
event. Thus, the proliferative vasculopathy might be a
response to loss of brain tissue. Vascular proliferation (neo-
vascularisation) occurs as part of the reparative process
following hypoxic-ischemic and traumatic brain injury.
However, the proliferation occurs only in areas of damage
to the brain tissue. An alternative hypothesis is that the
CNS proliferative vasculopathy is the primary event and
produces focal ischemic necrosis of adjacent white and
gray matter, with neuronal loss, calciﬁcation, and gliosis.
In Fowler syndrome, the proliferative vasculopathy seems
to be invariable and the key diagnostic feature, being
found in areas of otherwise preserved brain tissue,Figure 4. Localization of Mutations in a
Schematic Diagram of the FLVCR2 Gene
Product that Comprises Twelve Trans-
membrane Domains
Asn110_Phe112delinsIle and Leu398Val
are predicted to be in an extracellular
loop whereas Pro280Arg and Thr430Arg
are probably in an intracellular loop. The
nonsense mutation Ser158X is probably
located in transmembrane domain 3. The
mutated amino acid residues are shown
in red circles and the surrounding amino
acids are in white circles.
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Figure 5. Embryonal Expression of Mfsd7c the Mouse Ortholog
of FLVCR2
(A) Endoglin expression at E12.5 by in situ hybridization showing
expression in endothelial cells (blue) throughout the embryo.
(B) Magniﬁcation of the embryo in panel A showing the form of
endothelial cells at the hindbrain level.
(C) Flvcr2 expression in an E14.5 embryo taken from Genepaint22
(ID: EH275 Gene: BC011209). Note the similarity in form to endo-
glin expression.
(D) Sagittal brain image taken from the Allen Brain Atlas23 (Allen
Brain Atlas [Internet]. Seattle (WA): Allen Institute for Brain
Science. ª 2004– [cited 1/2/10], (Section ID BC011209_80)).
(E) Transverse image of the spinal cord taken from the Allen
Brain Atlas23 (Allen Brain Atlas [Internet]. Seattle (WA): Allen Insti-
tute for Brain Science. ª 2004– [cited 1/2/10], (Section ID
100009650-BC011209-4.0-116)).
(F) Magniﬁcation of the image of D at the brain stem level,
showing expression in endothelial-like cells. The analysis of endo-
glin expression was performed as described previously.30suggesting that the vascular proliferation is the primary
abnormality.2,4,13 Although expression of themouse Flvcr2
ortholog (Mfsd7c; NM_145447; BC011209) has not yet
been annotated in publicly available databases, closer476 The American Journal of Human Genetics 86, 471–478, March 1examination of in situ hybridization images in Gene-
paint22 and the Allen Brain Atlas23 revealed that themouse
Flvcr2 ortholog has strong and widespread expression
throughout the adult brain and spinal cord (Figure 5). Of
particular note, with regard to human glomeruloid vascul-
opathy, is the similar localization of Endoglin and Flvcr2 in
endothelial-like cells (Figure 5).
Fowler syndrome often presents with a FADS phenotype.
FADS is a heterogeneous disorder. In some cases FADS
may be caused by mutations in genes encoding compo-
nents of the embryonal acetylcholine receptor,24–28 but
in many cases the cause is unknown. Two cases of Fowler
syndrome were detected in a series of 30 cases of FADS,29
but Fowler syndrome (with the characteristic histopatho-
logical ﬁndings) has also been reported in the absence of
FADS. Hydrocephalus is usually diagnosed on prenatal
ultrasonography, and although macroscopic examination
at autopsy of Fowler syndrome cases generally suggests
hydranencephaly (replacement of the forebrain by a
ﬂuid-ﬁlled sac bounded only by meninges), histopatho-
logical examination reveals severe hydrocephalus with
(1) a remnant of the cortical mantle present around the
cerebral ventricles and (2) in most cases, a normal under-
lying brain structure. The diagnosis of Fowler syndrome
is complicated by variability of the clinical presentation.
In addition to presentation with hydrocephalus or ptery-
gia/FADS in the ﬁrst trimester, other cases present in
mid-second trimester. The differential diagnosis includes
other causes of hydrocephalus and fetal akinesia (e.g.,
cerebro-ocular-dysplasia-muscular dystrophy, Walker-War-
burg syndrome [MIM 236670] and Fukuyama congenital
muscular dystrophy [MIM 253800]) and apparently iso-
lated FADS or hydrocephalus/true hydranencephaly.
Although the neuropathology is pathognomonic and can
readily distinguish Fowler syndrome from isolated hydro-
cephalus, etc., an autopsy may be unavailable. Hence,
the identiﬁcation of germline mutations in FLVCR2 will
enable genetic testing in suspected cases and will, in addi-
tion to allowing carrier testing and earlier prenatal diag-
nosis, provide a basis for determining the frequency and
range of the phenotype of Fowler syndrome.Acknowledgments
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